Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Lung Cancer

Free Subscription 27.05.2024 1 Am J Clin Oncol 1 Ann Surg Oncol 3 Ann Thorac Surg 6 BMC Cancer 1 Cancer Cell 1 Cancer Epidemiol Biomarkers Prev 2 Cancer Lett 2 Carcinogenesis 1 Clin Cancer Res 3 Clin Lung Cancer 1 Clin Nucl Med 2 Eur J Cancer 2 Eur J Cardiothorac Surg 1 Hum Pathol 1 Int J Cancer 1 Int J Oncol 2 J Cancer Res Clin Oncol 2 J Thorac Cardiovasc Surg 1 J Thorac Oncol 1 JAMA Oncol 1 Lancet 2 Lung Cancer 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Oncol

1. XU J, Tian L, Qi W, Lv Q, et al
   Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments.
   Am J Clin Oncol. 2024;47:291-303.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. AL-KASSPOOLES M, Wilkerson J
   Is Radiomics Ready for Prime Time in Managing Non-small Cell Lung Cancer?
   Ann Surg Oncol. 2024 May 18. doi: 10.1245/s10434-024-15406.
   PubMed        
   
   

   
   Ann Thorac Surg

3. SAWABATA N, Hamaji M, Yoshikawa D, Miyata R, et al
   Clustered circulating tumor cells as a predictor of adjuvant-chemotherapy efficacy in lung cancer.
   Ann Thorac Surg. 2024 May 22:S0003-4975(24)00379.
   PubMed         Abstract available
   
   
4. BRIBRIESCO A
   Aim Local, Expect Global-EGFR and Recurrence in Stage I Lung Adenocarcinoma.
   Ann Thorac Surg. 2024;117:1119-1120.
   PubMed        
   
   
5. YANG F, Sun K, Li F, Li X, et al
   The Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Clinical Stage I Lung Adenocarcinoma.
   Ann Thorac Surg. 2024;117:1111-1119.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. HAYASHI Y, Ueyama A, Funaki S, Jinushi K, et al
   In situ analysis of CCR8(+) regulatory T cells in lung cancer: suppression of GzmB(+) CD8(+) T cells and prognostic marker implications.
   BMC Cancer. 2024;24:627.
   PubMed         Abstract available
   
   
7. LI W, Wu J, Jia Q, Shi Y, et al
   PD-L1 knockdown suppresses vasculogenic mimicry of non-small cell lung cancer by modulating ZEB1-triggered EMT.
   BMC Cancer. 2024;24:633.
   PubMed         Abstract available
   
   
8. ZHAO W, Liu Y, Yang Y, Wang L, et al
   New link between RNH1 and E2F1: regulates the development of lung adenocarcinoma.
   BMC Cancer. 2024;24:635.
   PubMed         Abstract available
   
   
9. LIN X, Wang F, Li Y, Lei F, et al
   Exploring shared decision-making needs in lung cancer screening among high-risk groups and health care providers in China: a qualitative study.
   BMC Cancer. 2024;24:613.
   PubMed         Abstract available
   
   
10. PRETE M, Ballarin G, Porciello G, Arianna A, et al
    Bioelectrical impedance analysis-derived phase angle (PhA) in lung cancer patients: a systematic review.
    BMC Cancer. 2024;24:608.
    PubMed         Abstract available
    
    
11. LIAO S, Wang Y, Zhou J, Liu Y, et al
    Associations between chronic obstructive pulmonary disease and ten common cancers: novel insights from Mendelian randomization analyses.
    BMC Cancer. 2024;24:601.
    PubMed         Abstract available
    
    

    
    Cancer Cell

12. FINLAY JB, Ireland AS, Hawgood SB, Reyes T, et al
    Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer.
    Cancer Cell. 2024 May 20:S1535-6108(24)00164-8. doi: 10.1016/j.ccell.2024.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

13. MURPHY SE, Guillermo C, Thomson NM, Carmella SG, et al
    Association of urinary biomarkers of tobacco exposure with lung cancer risk in African American and White cigarette smokers in the Southern Community Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed         Abstract available
    
    

    
    Cancer Lett

14. HE Q, Qu M, Xu C, Wu L, et al
    Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2/AT2-like cell differentiation.
    Cancer Lett. 2024;592:216922.
    PubMed         Abstract available
    
    
15. GUGNONI M, Lorenzini E, Torricelli F, Donati B, et al
    Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in malignant pleural mesothelioma.
    Cancer Lett. 2024;592:216950.
    PubMed         Abstract available
    
    

    
    Carcinogenesis

16. PAN C, Wang Q, Wang H, Deng X, et al
    LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1.
    Carcinogenesis. 2024;45:311-323.
    PubMed         Abstract available
    
    
17. WEI S, Ai M, Zhan Y, Yu J, et al
    TRIM14 suppressed the progression of NSCLC via hexosamine biosynthesis pathway.
    Carcinogenesis. 2024;45:324-336.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

18. FUKUDA A, Okuma Y
    From Rarity to Reality: Osimertinib's Promising Horizon in Treating Uncommon EGFR Mutations in Non-Small Cell Lung Cancer.
    Clin Cancer Res. 2024 May 20. doi: 10.1158/1078-0432.CCR-23-4035.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

19. NONAKA Y, Isaka M, Matsushima K, Katsumata S, et al
    Prediction of Pleural Lavage Cytology According to Thin-Section Computed Tomography in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2024 Apr 16:S1525-7304(24)00053.
    PubMed         Abstract available
    
    
20. SRIDHAR A, West HJ, Singhi EK
    Brief Report on Global Clinician Practices in the First-Line Management of Metastatic Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2024 Apr 30:S1525-7304(24)00068.
    PubMed         Abstract available
    
    
21. ROBERTS HN, Solomon B, Harden S, Lingaratnam S, et al
    Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer.
    Clin Lung Cancer. 2024 Apr 6:S1525-7304(24)00045.
    PubMed         Abstract available
    
    

    
    Clin Nucl Med

22. CHUN IK, Lee S
    Papillary Thyroid Cancer, Small Cell Lung Cancer, and Parathyroid Adenoma Synchronously Visualized on 99mTc-MIBI SPECT/CT in a Patient With Hyperparathyroidism: Comparison With 18F-FDG PET/CT.
    Clin Nucl Med. 2024 May 23. doi: 10.1097/RLU.0000000000005267.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

23. BLASI M, Kuon J, Luders H, Misch D, et al
    Corrigendum to "First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations" [Eur J Cancer 199 (2024) 113556].
    Eur J Cancer. 2024 May 24:114130. doi: 10.1016/j.ejca.2024.114130.
    PubMed        
    
    
24. CARRIL-AJURIA L, Lavaud P, Dalban C, Negrier S, et al
    Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma.
    Eur J Cancer. 2024;204:114048.
    PubMed         Abstract available
    
    

    
    Eur J Cardiothorac Surg

25. LI K, Li B, Yang J
    Optimal lymphadenectomy should be based on number or location or both?
    Eur J Cardiothorac Surg. 2024;65:ezae190.
    PubMed        
    
    
26. 
    Corrigendum to: Minimally invasive surgery for clinical T4 non-small-cell lung cancer: national trends and outcomes; Is underutilization of adjuvant therapy in resected non-small-cell lung cancer associated with socioeconomic disparities?; and Subloba
    Eur J Cardiothorac Surg. 2024;65:ezae203.
    PubMed        
    
    

    
    Hum Pathol

27. SUN W, Qu L, Wu J, Liu X, et al
    "Percentage" and "size" of residual viable tumor in lymph node, the performance in estimating pathologic response of lymph node in non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy.
    Hum Pathol. 2024 May 21:S0046-8177(24)00093.
    PubMed         Abstract available
    
    

    
    Int J Cancer

28. WANG Z, Zhang Q, Wang C, Herth FJF, et al
    Multiple primary lung cancer: Updates and perspectives.
    Int J Cancer. 2024 May 23. doi: 10.1002/ijc.34994.
    PubMed         Abstract available
    
    

    
    Int J Oncol

29. TAYLOR J, Dubois F, Bergot E, Levallet G, et al
    Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).
    Int J Oncol. 2024;65:68.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

30. LI X, Wu D, Tang J, Wu Y, et al
    The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort.
    J Cancer Res Clin Oncol. 2024;150:271.
    PubMed         Abstract available
    
    
31. WANG X, Xu Z, Zhao S, Song J, et al
    A novel subtype based on driver methylation-transcription in lung adenocarcinoma.
    J Cancer Res Clin Oncol. 2024;150:269.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

32. YAN H, Niimi T, Matsunaga T, Fukui M, et al
    Preoperatively Predicting Survival Outcome for Clinical Stage IA Pure-Solid Non-Small Cell Lung Cancer by Radiomics-based Machine Learning.
    J Thorac Cardiovasc Surg. 2024 May 22:S0022-5223(24)00441.
    PubMed         Abstract available
    
    
33. XU L, Si H, Zhuang F, Li C, et al
    Predicting therapeutic response to neoadjuvant immunotherapy based on an integration model in resectable stage IIIA (N2) non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2024 May 17:S0022-5223(24)00437.
    PubMed         Abstract available
    
    

    
    J Thorac Oncol

34. ROCCO G, Pennazza G, Tan KS, Vanstraelen S, et al
    A real-world assessment of stage I lung cancer through electronic nose technology.
    J Thorac Oncol. 2024 May 16:S1556-0864(24)00211.
    PubMed         Abstract available
    
    

    
    JAMA Oncol

35. CHAUNZWA TL, Qian JM, Li Q, Ricciuti B, et al
    Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy.
    JAMA Oncol. 2024 May 23. doi: 10.1001/jamaoncol.2024.1120.
    PubMed         Abstract available
    
    

    
    Lancet

36. GIJTENBEEK RG, Noordhof AL, Asmara OD, Groen HJ, et al
    Immunotherapy in frail non-small-cell lung cancer patients.
    Lancet. 2024;403:1986.
    PubMed        
    
    

    
    Lung Cancer

37. FELIP E, Metro G, Tan DSW, Wolf J, et al
    Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non-small cell lung cancer.
    Lung Cancer. 2024;192:107820.
    PubMed         Abstract available
    
    
38. LI Y, Wong M, Zhan L, Corke L, et al
    Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort.
    Lung Cancer. 2024;192:107823.
    PubMed         Abstract available
    
    

    
    PLoS One

39. BIANCHI F, Le Noci V, Bernardo G, Gagliano N, et al
    Cigarette smoke sustains immunosuppressive microenvironment inducing M2 macrophage polarization and viability in lung cancer settings.
    PLoS One. 2024;19:e0303875.
    PubMed         Abstract available
    
    
40. LUO W, Chang G, Lin D, Xie H, et al
    3,3'-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration.
    PLoS One. 2024;19:e0303186.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.